{"id":2004,"date":"2017-12-31T00:00:37","date_gmt":"2017-12-30T17:00:37","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=2004"},"modified":"2022-03-30T09:56:41","modified_gmt":"2022-03-30T02:56:41","slug":"a-phase-ii-iii-open-label-study-of-the-pharmacokinetics-safety-and-antiviral-activity-of-the-elvitegravir-cobicistat-emtricitabine-tenofovir-disoproxil-fumarate-single-tablet-regimen-str-in-hiv","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/2004\/","title":{"rendered":"A phase 2\/3, open-label study of the pharmacokinetics, safety, and antiviral activity of the Elvitegravir\/Cobicistat\/Emtricitabine\/Tenofovir disoproxil fumarate single tablet regimen (STR) in HIV-1 infected antiretroviral treatment-naive adolescents"},"content":{"rendered":"\n<p>This study is to evaluate the steady-state\npharmacokinetics (PK) and confirm the dose of the\nelvitegravir\/cobicistat\/emtricitabine\/tenofovir disoproxil fumarate\n(EVG\/COBI\/FTC\/TDF) single tablet regimen (STR) in HIV-1 infected,\nantiretroviral (ARV) treatment-naive adolescents. Safety, tolerability, and\nefficacy will also be evaluated through Week 48. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tThis study is to evaluate the steady-state pharmacokinetics (PK) and confirm the dose of the elvitegravir\/cobicistat\/emtricitabine\/tenofovir disoproxil fumarate (EVG\/COBI\/FTC\/TDF) single tablet regimen (STR) in HIV-1 infected, antiretroviral (ARV) treatment-naive adolescents.\t\t<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-2004","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=2004"}],"version-history":[{"count":1,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2004\/revisions"}],"predecessor-version":[{"id":3327,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2004\/revisions\/3327"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=2004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=2004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=2004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}